The global transplant diagnostics market is projected to
reach USD 4.91 billion by 2023 from 3.44 billion in 2018, at a CAGR of 7.4%.
Factors such as the increasing public-private funding for target research
activities, growing burden of infectious diseases, increasing number of
transplant procedures, and increasing public awareness about organ donation and
transplantation across emerging countries are driving the growth of the
transplant diagnostics market.
Download Free Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=2531061
What This Report Will Provide?
The study involved four major activities in estimating the
current size of the transplant diagnostics market. Exhaustive secondary
research was conducted to collect information on the market and its different
subsegments. The next step was to validate these findings, assumptions, and
sizing with industry experts across the value chain through primary research.
On the basis of product, the transplant diagnostics market
is segmented into reagents & consumables, instruments, and software &
services. The reagents & consumables segment is expected to account for the
highest growth rate of the transplant diagnostics market during the forecast
period. The high growth can be attributed to the expansion in the application
horizons of molecular assay techniques in transplant diagnostics (owing to
better accuracy, high turnaround time, capability to analyze multiple samples
in a single process, and early detection of donor-recipient incompatibility).
Browse and in-depth TOC on “Transplant Diagnostics
Market”
60 – Figures
203 – Pages
Based on technology, the transplant diagnostics market is
segmented into molecular and non-molecular assays. The molecular assays segment
is expected to account for the highest growth rate of the transplant
diagnostics market during the forecast period. The high growth can be
attributed to the demand for molecular assays and its varied applications in
patient profiling, rising public-private investments to support product
development, increasing clinical evidence to establish clinical efficacy of
molecular assays, and technological advancements (such as PCR and NGS).
On the basis of transplant type, the transplant diagnostics
market is segmented into solid organ, stem cell, and soft tissue
transplantation. The solid organ transplantation segment is expected to account
for the highest growth rate of the transplant diagnostics market during the
forecast period. The high growth can be attributed to the increasing number of
solid organ transplantation procedures and supportive government regulations to
increase organ donations across major healthcare markets.
Based on application, the global transplant diagnostics
market is segmented into diagnostic and research applications. The diagnostic
applications market is further segmented into pre-transplantation (infectious
diseases testing, histocompatibility testing, and blood profiling) and
post-transplantation diagnostic applications. The pre-transplantation is
expected to account for the highest growth rate of the transplant diagnostics
market in 2018. The high CAGR of this segment is attributed to ongoing
technological advancements in the field of molecular assay techniques (such as
SSO, PCR, and NGS) and increasing adoption of molecular assay procedures for
pathogen detection and histocompatibility testing.
On the basis of end user, the independent reference
laboratories segment is expected to grow at the highest CAGR during the
forecast period. This growth can be attributed to the rapid modernization and
automation of diagnostic laboratories and growing number of research &
development activities outsourced by pharmaceutical & biotechnology
companies to independent reference laboratories.